← SynDRA
PKI.179
SynDRA canonical compound SYN1970627 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MTOR |
|---|
| Mechanism of action | mTOR inhibitor | PI3K inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MTOR inhibitor
- PI3K inhibitor
Cross-references
Synonyms
- PKI-179
- 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-4-yl)urea
- CHEMBL1258517
- 1-[4-[4-morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]phenyl]-3-pyridin-4-ylurea
- SCHEMBL1409445
- BDBM50327419
- HY-11080
- CS-0003039
- PI 3-K/mTOR Inhibitor III, PKI-179 - CAS 1197160-28-3
- 1-[4-[4-Morpholino-6-(3-oxa-8-azabicyclo[3.2.1]octane-8-yl)-1,3,5-triazine-2-yl]phenyl]-3-(4-pyridyl)urea
- 1-{4-[4-morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]oct-8-yl)-1,3,5-triazin-2-yl]phenyl}-3-pyridin-4-ylurea
Look up PKI.179 in the interactive SynDRA portal →